Search

The integration of artificial intelligence (AI) into healthcare systems has revolutionized clinical analytics, enabling enhanced diagnostic accuracy, predictive modeling, and personalized treatment pathways. However, the opacity of many AI models poses significant challenges to their clinical adoption, necessitating advancements in explainable AI (XAI) to ensure interpretability and transparency. This narrative review synthesizes the literature on XAI within clinical systems, focusing on interpretability mechanisms, transparency frameworks, and deployment constraints in healthcare analytics. Drawing from high-impact studies, we examine how XAI addresses the “black box” nature of machine learning models in high-stakes medical decisions, particularly in contexts where performance has traditionally been prioritized over explainability. Key themes include the shift toward inherently interpretable models for critical applications, such as diagnostic imaging and predictive analytics, where post-hoc explanations often fall short. We explore the ethical imperatives for responsible AI deployment, including strategies for mitigating harm through transparent systems that align with clinical workflows. The review integrates perspectives on XAI in clinical diagnostics, emphasizing challenges in balancing model complexity with user trust. Transparency is framed not merely as a technical feature but as a systemic requirement, incorporating structured reporting practices for AI interventions and standardized modeling approaches. Deployment constraints are analyzed through the lens of real-world integration, including regulatory considerations, data privacy concerns, and human–AI interaction dynamics in healthcare infrastructures. We synthesize evidence from diverse applications, such as lung cancer diagnosis via explainable models and radiographic assessments, underscoring the need for multidisciplinary approaches to XAI. Furthermore, the review highlights biases in AI systems, particularly sex and gender disparities, and advocates for inclusive analytics to foster equitable healthcare. Clinical applications beyond the black box are discussed, with calls for standardized reporting to enhance reproducibility and trust. We position XAI as essential for closed-loop systems that incorporate feedback mechanisms, ensuring ongoing model recalibration in dynamic clinical environments. The synthesis reveals persistent gaps in current XAI deployments, such as overreliance on surrogate explanations that may mislead clinicians. Ultimately, this review proposes a systems-level framework for XAI in healthcare, integrating data ingestion, inference, decision support, and governance loops to overcome transparency barriers. This comprehensive overview informs the development of future AI-enabled healthcare infrastructures, emphasizing interpretability as a cornerstone for safe and effective clinical analytics.

The integration of multi-modal intelligence in healthcare represents a transformative paradigm, where artificial intelligence (AI) systems synthesize diverse clinical data streams—ranging from electronic health records (EHRs), imaging, genomics, and wearable sensor data—to enable more cohesive, predictive, and actionable insights. This narrative review synthesizes recent advancements in AI for healthcare systems and analytics, focusing on conceptual integration patterns that bridge disparate data modalities to enhance clinical decision-making and system-level efficiencies. We explore how multi-modal AI frameworks address the heterogeneity of healthcare data, fostering intelligent systems that support precision health, risk stratification, and closed-loop interventions. Key themes include the evolution of multi-modal machine learning techniques, such as fusion models that combine radiological imaging with clinical parameters for improved diagnostic accuracy, and the role of large language models (LLMs) in processing unstructured textual data alongside structured metrics. For instance, integrated frameworks leverage deep residual networks and transformers to handle multimodal inputs, enabling applications in areas like pulmonary hypertension prediction and Alzheimer’s disease progression forecasting. We highlight systems-level architectures that incorporate feedback loops for continuous model refinement, emphasizing the need for robust data modeling in federated learning environments to ensure privacy and interoperability across healthcare infrastructures. Challenges in data fusion, such as handling dataset shifts and ensuring equitable access to digital health tools, are contextualized within broader analytics pipelines. The review underscores original synthesis logic by framing integration patterns through a systems lens: data ingestion, intelligent inference, decision support, and governance. This approach reveals how multi-modal AI not only amplifies analytic capabilities but also redefines healthcare delivery models, from virtual biopsies using mammography data to comprehensive communication skills training for physicians via AI-driven video analysis. Ultimately, this synthesis positions multi-modal intelligence as a cornerstone for next-generation healthcare systems, promoting seamless interoperability and human-AI collaboration. By avoiding empirical benchmarks and focusing on conceptual patterns, we provide an interpretive framework that guides future deployments, ensuring AI enhances rather than disrupts clinical workflows.

The integration of artificial intelligence (AI) into healthcare systems has transformed population health analytics, enabling scalable infrastructures that process vast datasets to inform clinical decisions, resource allocation, and policy-making. This narrative review synthesizes recent literature on AI system architectures and governance models, focusing on how these elements underpin analytics-driven healthcare ecosystems. We examine the evolution of AI-enabled infrastructures, emphasizing federated learning, explainable models, and ethical frameworks to address data privacy, interoperability, and equity in population-level analytics. Key architectures include vertically integrated systems that streamline data ingestion, model deployment, and real-time inference, as seen in federated approaches that mitigate data silos while preserving patient confidentiality. Governance models are critical for ensuring trustworthy AI deployment, incorporating regulatory oversight, ethical principles adapted from military contexts to healthcare, and consensus-based guidelines for prediction models. We highlight the role of blockchain and data trusts in enhancing transparency and consent mechanisms, particularly in global health responses to pandemics and chronic disease management. The review structures the discourse around systems-level framing, integrating data flows, algorithmic decision support, and closed-loop feedback mechanisms that adapt to clinical outcomes. For instance, electronic health record (EHR)-based prediction models facilitate acute illness forecasting and outcome prediction in conditions like rheumatoid arthritis and oncology. We propose an original synthesis logic that conceptualizes AI infrastructures as adaptive networks, where governance acts as a regulatory layer overlaying architectural components to balance innovation with risk mitigation. Challenges such as bias in commercial datasets and the need for international cooperation are noted, but the emphasis remains on infrastructural resilience. Ultimately, this synthesis underscores the imperative for hybrid human-AI systems that prioritize population health equity, with governance models evolving to support sustainable analytics infrastructures. By positioning AI as a foundational tool for healthcare transformation, the review advocates for interdisciplinary collaboration to refine these systems, ensuring they deliver actionable insights while upholding ethical standards in diverse healthcare settings.

The integration of large language models (LLMs) into clinical healthcare systems represents a transformative shift in how data analytics, decision support, and operational infrastructure are conceptualized and deployed. This narrative review synthesizes recent advancements in LLMs within healthcare, focusing on their roles in enhancing clinical analytics, infrastructural frameworks, and oversight mechanisms while addressing inherent risk dynamics. Drawing from peer-reviewed literature, we examine how LLMs facilitate the processing of vast unstructured clinical data, such as electronic health records and patient narratives, to generate actionable insights that inform diagnostics, treatment planning, and resource allocation. Key infrastructural elements include scalable deployment pipelines that integrate LLMs with existing hospital information systems, enabling real-time analytics and predictive modeling without disrupting legacy workflows. Oversight is emphasized through regulatory frameworks that ensure ethical deployment, data privacy compliance, and bias mitigation, as LLMs amplify risks related to misinformation, algorithmic opacity, and equitable access in diverse clinical settings. Risk dynamics are explored in terms of model hallucinations, dependency on training data quality, and potential for exacerbating healthcare disparities if not properly governed. The review highlights systems-level analytics where LLMs contribute to closed-loop healthcare ecosystems, from data ingestion and inference to feedback-driven recalibration, fostering adaptive intelligence in clinical decision-making. For instance, LLMs have been adapted for tasks like text summarization, diagnostic reasoning, and patient communication, outperforming traditional methods in efficiency while requiring robust validation to maintain clinical fidelity. We underscore the need for interdisciplinary collaboration between clinicians, data scientists, and policymakers to harness LLMs' potential in optimizing healthcare delivery. By synthesizing cross-study evidence, this review proposes an original interpretive framework for LLM-enabled healthcare systems, structured around data-model-deployment-governance cycles, to guide future implementations. Ultimately, while LLMs promise enhanced analytics and infrastructural resilience, their clinical adoption demands vigilant oversight to balance innovation with patient safety and ethical integrity. This synthesis not only maps the current landscape but also identifies infrastructural gaps in scaling LLMs for equitable, high-stakes clinical environments, paving the way for more resilient healthcare analytics paradigms.

Generative artificial intelligence (GenAI) has emerged as a transformative force in healthcare systems, enabling advanced analytics, personalized interventions, and streamlined governance frameworks. This narrative review synthesizes recent literature on GenAI’s integration into healthcare infrastructures, emphasizing systems governance, safety protocols, and accountability mechanisms. We explore how GenAI enhances clinical decision-making, data analytics, and closed-loop systems while addressing ethical, regulatory, and operational challenges.At the core of healthcare systems, GenAI facilitates intelligent analytics by generating synthetic data for training models, simulating patient outcomes, and optimizing resource allocation. Governance frameworks are critical for ensuring responsible deployment, with studies highlighting the need for institutional guidelines that mitigate risks such as bias amplification and data privacy breaches. Safety considerations encompass algorithmic transparency, error detection in generative outputs, and human oversight in clinical loops. Accountability extends to lifecycle management, from model development to post-deployment monitoring, as evidenced by global initiatives and regional models like those in the GCC.The review delineates the landscape of GenAI applications in healthcare analytics, including predictive modeling for chronic disease management and real-time decision support. We propose an original systems-level framing that integrates data ingestion, inference generation, intervention deployment, and feedback recalibration under governance umbrellas. This synthesis reveals gaps in current infrastructures, such as the lack of standardized AI guardians for information overload and the challenges of scaling enterprise AI.In examining intelligent clinical decision systems, we highlight architectures that fuse GenAI with electronic health records (EHRs) for closed-loop operations, where generative models inform adaptive interventions. Ethical considerations are woven throughout, advocating for principles adapted from military contexts to healthcare. The adoption of GenAI in US hospitals underscores its potential for inpatient summaries and chronic care, yet calls for regulatory oversight to align with Helsinki declarations.Ultimately, this review positions GenAI as a cornerstone for accountable healthcare systems, urging interdisciplinary collaboration to balance innovation with safety. By synthesizing governance models, safety protocols, and accountability structures, we provide a roadmap for sustainable integration, fostering equitable health outcomes in an AI-augmented era.

The integration of artificial intelligence (AI) into healthcare systems and analytics represents a transformative shift toward more efficient, personalized, and predictive clinical practices. However, this evolution necessitates robust governance frameworks to ensure transparency, mitigate biases, and enable continuous lifecycle monitoring. This narrative review synthesizes recent literature on AI governance in healthcare, focusing on systems-level infrastructure and clinical analytics. Drawing from peer-reviewed publications, we examine how AI tools enhance healthcare delivery through data-driven insights while addressing ethical, regulatory, and operational challenges.Central to AI governance is transparency, which involves making algorithmic processes interpretable to clinicians and stakeholders. Studies highlight the need for explainable AI models in clinical decision-making, where opaque “black-box” systems can undermine trust and accountability. For instance, frameworks for implementing machine learning in healthcare emphasize ethical considerations, such as disclosing model limitations and decision rationales to prevent misinformed clinical actions. Bias mitigation emerges as a critical pillar, with research demonstrating how algorithmic biases in electronic health records can perpetuate health disparities, particularly among underrepresented populations. Strategies include proactive monitoring of algorithms for equity, incorporating diverse datasets during development, and post-deployment audits to detect and correct biases.Lifecycle monitoring models ensure sustained performance and safety of AI systems over time. This encompasses ongoing evaluation, recalibration, and governance structures that adapt to evolving clinical environments. Nationwide initiatives propose AI assurance laboratories to standardize monitoring, while institutional guidelines advocate for step-by-step implementation to avoid “AI winters” caused by unaddressed failures. In analytics contexts, large AI models facilitate health informatics by processing vast datasets for predictive analytics, yet they require governance to handle challenges like data privacy and model drift.The review structures its synthesis around healthcare systems’ end-to-end loops: from data ingestion to intelligent decision support and closed-loop interventions. It integrates cross-study analyses to propose original interpretive models for governance, emphasizing human-AI collaboration in clinical workflows. Key findings underscore the importance of multidisciplinary approaches, combining technical, ethical, and regulatory perspectives to foster responsible AI adoption. Ultimately, effective governance not only enhances patient outcomes but also builds public trust in AI-driven healthcare. This synthesis highlights gaps in current practices and advocates for integrative monitoring systems to realize AI’s full potential in equitable healthcare delivery.

The integration of artificial intelligence (AI) into healthcare systems has revolutionized clinical analytics, enabling predictive modeling, diagnostic support, and personalized interventions. However, the post-deployment phase of these AI systems presents unique challenges, particularly in maintaining performance amid evolving clinical environments. This narrative review synthesizes recent literature on post-deployment monitoring strategies for clinical AI, focusing on drift detection, feedback governance, and update policies within healthcare systems and analytics frameworks. We examine how data shifts—arising from changes in patient demographics, clinical protocols, or external factors—can degrade AI model efficacy, leading to suboptimal outcomes in high-stakes settings like disease prediction and resource allocation. Drift detection emerges as a cornerstone, encompassing statistical methods to identify concept drift, covariate shift, and label drift in real-time healthcare data streams. Techniques such as nonparametric monitoring and ensemble-based approaches allow for proactive identification of performance decay, ensuring AI systems remain aligned with dynamic clinical realities. Feedback governance integrates human-in-the-loop mechanisms, where clinician inputs refine AI outputs, fostering trust and regulatory compliance in governance structures. Update policies, including retraining schedules and federated learning paradigms, to address the need for iterative model evolution without disrupting clinical workflows. We highlight systems-level perspectives, such as closed-loop architectures that link monitoring to automated updates, emphasizing interoperability across electronic health records (EHRs) and AI pipelines. Comparative analysis reveals gaps in current practices, including limited scalability in resource-constrained settings and ethical considerations in data privacy during monitoring. Through an original synthesis, we propose an integrative framework for AI lifecycle management in healthcare, underscoring the interplay between drift metrics, governance protocols, and policy-driven updates to enhance patient safety and system resilience. This review underscores the imperative for standardized monitoring protocols, informed by multidisciplinary insights, to bridge the translational gap from AI development to sustained clinical utility. By addressing these elements, healthcare AI can achieve robust, adaptive performance, ultimately improving analytics-driven decision-making and outcomes in diverse clinical contexts. Future directions include harmonizing international guidelines for AI monitoring, integrating explainable AI for better feedback loops, and leveraging emerging technologies like edge computing for real-time drift management. This synthesis provides a foundation for researchers and practitioners to advance post-deployment strategies, ensuring AI’s enduring impact on healthcare systems.

The integration of retrieval-augmented generation (RAG) into healthcare systems represents a transformative approach to enhancing the reliability, interpretability, and safety of artificial intelligence (AI)-driven clinical analytics. By combining large language models (LLMs) with external knowledge retrieval mechanisms, RAG mitigates hallucinations inherent in standalone generative models, ensuring outputs are grounded in verifiable evidence from electronic health records (EHRs), clinical guidelines, and peer-reviewed literature. This narrative review synthesizes recent advancements in RAG applications for healthcare, focusing on evidence-grounded strategies, tailored evaluation metrics, and robust safety controls to facilitate trustworthy deployment in high-stakes medical environments. Evidence grounded in RAG frameworks involves dynamic retrieval of contextually relevant information to inform generative responses, thereby improving factual accuracy in tasks such as clinical summarization, decision support, and patient education. Studies demonstrate that RAG-enhanced LLMs outperform traditional models in extracting key clinical insights from EHRs, with applications spanning orthopedic patient education, neurosurgical consultations, and precision oncology treatment matching. For instance, integrating vector databases with LLMs enables real-time querying of molecular data to align therapeutic recommendations with patient-specific profiles, reducing errors in evidence-based practice. However, the efficacy of grounding depends on the quality of retrieved sources, necessitating hybrid retrieval techniques that balance semantic similarity and domain-specific relevance. Evaluation metrics for RAG in healthcare extend beyond conventional natural language processing benchmarks to incorporate clinical validity, coherence with medical knowledge, and user-centric outcomes. Metrics such as faithfulness scores, which assess alignment between generated content and retrieved evidence, have been adapted for biomedical contexts, revealing improvements in accuracy for tasks like fitness assessments and diabetes education. Safety controls are paramount, encompassing bias mitigation through multi-agent conversational frameworks, privacy-preserving retrieval in federated systems, and hallucination detection via uncertainty quantification. Regulatory perspectives emphasize the need for standardized safety benchmarks to prevent misinformation in patient-facing tools. This review highlights systems-level insights, including closed-loop architectures where RAG facilitates iterative feedback between data ingestion, inference, and clinical intervention. Challenges in scalability, such as computational overhead in resource-constrained settings, are addressed through optimized retrieval pipelines. We propose an original interpretive framework for RAG deployment, emphasizing interoperability with existing healthcare infrastructures to enhance analytics workflows. Ultimately, RAG holds promise for democratizing AI in healthcare, provided rigorous evaluation and safety protocols are embedded from design to implementation, paving the way for equitable, evidence-driven clinical intelligence.

The integration of generative artificial intelligence (AI) into clinical workflows represents a transformative shift in healthcare systems and analytics, promising enhanced efficiency in documentation tasks while introducing novel challenges in reliability and governance. This narrative review synthesizes recent literature on the utility of generative AI models, such as large language models (LLMs), in automating clinical documentation, including patient notes, discharge summaries, and diagnostic reports, which traditionally consume significant clinician time. Studies highlight how these tools can streamline data ingestion from electronic health records (EHRs), generating coherent narratives that align with clinical standards, thereby reducing administrative burdens and allowing more focus on patient care. For instance, generative AI has demonstrated proficiency in summarizing complex medical dialogues and classifying clinical notes, often outperforming traditional methods in speed and accuracy, as evidenced by evaluations in German healthcare settings and emergency departments. However, the utility is tempered by inherent failure modes, including hallucinations—where models produce factually incorrect information—and biases amplified from training data, which can propagate errors in clinical decision-making. Oversight mechanisms are critical to mitigate these risks, encompassing human-in-the-loop verification, regulatory frameworks like the EU AI Act, and ethical guidelines for deployment in high-stakes environments. From a systems-level perspective, generative AI enables closed-loop analytics in healthcare infrastructure, where data flows from ingestion to inference, informing interventions and feeding back for model recalibration. This review examines how LLMs facilitate intelligent clinical decision support, such as in patient care document verification using EHRs and prompt engineering for medical education. Yet, failures such as catastrophic errors in multimodal AI applications underscore the need for robust oversight, including transparency in model training and post-deployment monitoring. Comparative analyses reveal that while generative AI excels in low-risk documentation tasks, its application in critical sectors demands interdisciplinary expertise to address trust deficits and ensure equitable outcomes. The review integrates cross-study insights, proposing an original framework for AI-enabled healthcare loops that emphasizes governance at each stage to balance innovation with safety. Emerging perspectives indicate that generative AI’s role in healthcare analytics extends to predictive modeling and administrative functions, with consensus statements advocating for standardized evaluation frameworks to assess real-world viability. Challenges in failure modes, such as over-reliance on AI outputs without verification, highlight the imperative for oversight mechanisms that incorporate legal and ethical considerations, ensuring compliance with therapeutic approvals and preventing misuse in controlled substance contexts. Ultimately, this synthesis underscores the dual-edged nature of generative AI in clinical workflows: its documentation utility can revolutionize healthcare delivery, but only through vigilant oversight to avert failures that compromise patient safety. By structuring the discourse around data-model-deployment-governance continua, this review offers a novel interpretive lens for future implementations, urging stakeholders to prioritize human oversight in AI-augmented systems.

Transformer-based architectures have significantly advanced clinical natural language processing by improving the capture of contextual relationships in unstructured electronic health records compared to earlier recurrent and convolutional models, with domain-specific variants such as ClinicalBERT and BioBERT designed to better handle clinical terminology, abbreviations, and specialized language, thereby improving information extraction performance, although the relative impact of different pre-training strategies remains insufficiently synthesized and requires systematic evaluation of corpus selection and fine-tuning approaches; this systematic review mapped studies focusing on pre-training corpora, fine-tuning methods, and named entity recognition performance across entity types such as medications, diseases, procedures, laboratory tests, and social determinants of health, using PRISMA-guided methods and searches across PubMed, ACL Anthology, arXiv, and IEEE Xplore, identifying 32 eligible studies from 1,247 records; findings showed that ClinicalBERT, BioBERT, and PubMedBERT were the most frequently evaluated models, pre-trained on datasets such as MIMIC-III, PubMed abstracts, and mixed biomedical corpora, with consistent evidence that domain-specific pre-training outperforms general-domain BERT models on benchmarks like i2b2 and n2c2 despite variation across entity types and fine-tuning strategies, while clinical pre-training on large EHR corpora improves named entity recognition and optimized fine-tuning approaches such as lower learning rates and data augmentation further enhance performance, particularly for medications and diseases, underscoring the importance of domain adaptation and the need for more standardized evaluation protocols in clinical NLP research.

Patient no-shows in outpatient clinics (5%–30% across specialties) disrupt scheduling efficiency, increase wait times, and strain healthcare resources. To address this, healthcare systems are increasingly applying machine learning (ML) for predictive scheduling support. This systematic review synthesizes ML approaches for predicting outpatient no-shows, focusing on model types, feature usage, and reported operational deployment outcomes, with emphasis on translation into clinical scheduling practice. A PRISMA-compliant search of PubMed, Embase, IEEE Xplore, Scopus, and Web of Science identified studies using ML for no-show prediction in outpatient settings. Data on models, features, performance, and implementation were extracted. Risk of bias was assessed using an adapted PROBAST tool. Thirty-two studies were included. Logistic regression, random forest, and XGBoost were the most commonly used models. Historical attendance data was the dominant predictive feature. Fewer than 20% of studies reported real-world implementation, and reported intervention outcomes (e.g., overbooking, reminders) were inconsistent. While ML models show strong predictive performance, real-world deployment and evidence of operational impact remain limited. This gap highlights the need to prioritize implementation-focused research to translate predictive accuracy into measurable improvements in clinic efficiency and access.

Alzheimer’s disease (AD) is the leading cause of dementia, affecting over 50 million people worldwide, with prevalence expected to triple by 2050. Early detection is crucial for clinical trial enrollment and care planning, and multimodal data (MRI, PET, CSF biomarkers, and cognitive assessments) provides complementary information on neurodegeneration, metabolism, and protein aggregation. This systematic review synthesizes AI/ML approaches for early AD detection using multimodal data, focusing on fusion strategies and performance across disease stages. Following PRISMA guidelines, searches of PubMed, IEEE Xplore, Scopus, Web of Science, and arXiv (2017–2023) identified studies using ML/DL with at least two modalities and reporting diagnostic performance. From 1,247 records, 35 studies were included. MRI was the most used modality (>90%), followed by cognitive tests (70–80%), PET (40–50%), and CSF (20–30%). Early fusion was most common, with increasing use of intermediate fusion. Multimodal models achieved AUROC of 0.90–0.98 for AD vs controls, but lower performance (0.70–0.85) for predicting MCI conversion to AD. Overall, multimodal AI improves early AD detection, with strong performance for diagnosis but persistent challenges in forecasting MCI progression due to heterogeneity and limited longitudinal data.

The integration of artificial intelligence into clinical decision support systems offers improved diagnostic accuracy and efficiency, but the opacity of many machine learning models raises concerns about trust, accountability, and regulatory compliance. Explainable artificial intelligence (XAI) has been proposed to address this by making model predictions interpretable to clinicians; however, its true clinical value remains uncertain, and evaluation has not kept pace with methodological development. This systematic review aimed to identify XAI methods used in clinical decision support systems, assess how they are evaluated with clinicians, and determine whether explanations improve diagnostic accuracy, trust, mental models, and efficiency. Following PRISMA guidelines, we searched PubMed, Web of Science, IEEE Xplore, ACM Digital Library, and Scopus for studies published between 2017 and 2024. Eligible studies included original research evaluating XAI in clinical decision support systems with clinician participants and reporting quantitative or qualitative outcomes. Risk of bias was assessed using adapted QUADAS-2 and ROBIS tools, and findings were synthesized narratively with subgroup analyses. From 2,847 records, 68 studies were included. The most common XAI methods were SHAP-based feature attribution (38%), saliency or heatmap methods (29%), concept-based approaches such as TCAV (15%), and counterfactual or example-based explanations (12%). Radiology was the dominant field (54%), followed by dermatology (18%) and pathology (12%). Evaluation approaches were highly inconsistent, with few validated instruments and most studies relying on Likert-scale trust measures or qualitative feedback. Only 16% of studies showed improved diagnostic accuracy with explanations, 67% showed no significant effect, and 17% reported reduced accuracy due to over-reliance or misinterpretation. Although 82% of studies reported increased clinician trust, trust rarely correlated with actual diagnostic performance. Overall, while XAI methods are widely studied in clinical decision support, their evaluation is inconsistent and their benefits are limited. Explanations tend to increase clinician trust without reliably improving diagnostic accuracy, and may sometimes worsen performance, highlighting a trust–accuracy gap that poses important safety concerns for clinical deployment.

Federated learning (FL) is promoted as a privacy-preserving method for training machine learning models across healthcare institutions without sharing patient data, with growing use in medical imaging, electronic health records, and rare disease research. This critical review examines FL studies from 2017–2024, focusing on privacy guarantees, statistical heterogeneity, communication efficiency, and real-world clinical deployment. A structured search of PubMed, IEEE Xplore, arXiv, and Google Scholar was conducted using relevant FL and healthcare terms, including studies addressing privacy, heterogeneity, communication, or deployment. Reported privacy guarantees are often overstated, with most studies relying on FedAvg without differential privacy. Statistical heterogeneity in non-IID settings remains largely unresolved. Fewer than 5% of studies report real-world deployment, typically at very small scale. A significant gap exists between FL research and clinical application. Current methods fall short of healthcare-grade privacy and real-world constraints, limiting readiness for high-stakes clinical use.

Postoperative complications including SSI (2–20%), VTE (1–5%), and respiratory failure (1–8%) significantly increase morbidity, mortality, length of stay, and readmissions. This systematic review assessed machine learning models predicting these outcomes, their performance, external validation, and clinical deployment. A PRISMA-based search (2017–2024) identified 32 eligible studies. Models such as random forest and XGBoost showed AUROC ranges of 0.70–0.85 for SSI, 0.75–0.90 for VTE (outperforming Caprini scores), and 0.75–0.88 for respiratory failure. However, fewer than 20% of studies included external validation and less than 5% reported clinical deployment. Overall, while machine learning models show strong retrospective performance, limited validation and minimal real-world implementation remain major barriers to clinical translation.

Suicidality and depression are major global health burdens, with over 700,000 suicide deaths annually and ~280 million people affected by major depressive disorder. Early risk prediction could support prevention, but traditional methods show limited accuracy. This PRISMA-compliant systematic review evaluated machine learning models for predicting suicidality and depression across electronic health records, social media, and wearable sensor data, focusing on performance, unimodal vs multimodal approaches, and ethical reporting. Searches of PubMed, PsycINFO, IEEE Xplore, arXiv, and ACM Digital Library identified eligible studies. EHR-based models showed AUROC 0.70–0.85 for suicide attempt prediction, social media models 0.70–0.80 for suicidal ideation, and wearable sensor models lower performance (0.65–0.75). Multimodal approaches improved performance by 5–10% over unimodal models. However, fewer than 20% of studies reported ethical considerations such as privacy, bias, or deployment safeguards. Overall, machine learning shows moderate-to-good predictive performance, with multimodal models performing best, but ethical reporting remains critically insufficient for clinical translation.

Clinical documentation is central to continuity of care, coding, billing, compliance, and quality measurement, yet it remains a major source of administrative burden for physicians. Artificial intelligence, especially natural language processing, has been proposed as a way to improve documentation quality, coding accuracy, billing support, and clinical workflow efficiency. This systematic review synthesised evidence from 2017 to 2023 on natural language processing methods applied to clinical documentation improvement. The review focused on automated clinical coding, note quality, billing support, computer-assisted physician documentation, and physician workflow efficiency. A PRISMA 2020-compliant search strategy was applied to PubMed, Scopus, IEEE Xplore, and Web of Science for publications from 1 January 2017 to 31 December 2023. Screening was performed in duplicate, and eligible studies were narratively synthesised by documentation domain, model type, deployment maturity, and evaluation approach. The evidence base expanded rapidly during the review period, especially in automated coding and clinical note generation. Several studies reported technically promising systems for ICD coding, documentation summarisation, and speech-derived notes, whereas billing outcomes and sustained workflow effects were less commonly evaluated. Natural language processing for clinical documentation improvement appears most mature for automated coding and note analysis. Evidence for billing support and physician workflow transformation remains less developed, particularly in prospective clinical environments.

Efficient hospital resource allocation is a persistent operational challenge because demand for beds, staff, equipment, diagnostics, and patient movement changes rapidly. Predictive analytics offers a way to anticipate demand and support more proactive operational decisions. This systematic review synthesised machine learning models applied to hospital resource allocation from 2017 to 2023. The review focused on bed management, staffing demand, equipment use, diagnostic capacity, and patient throughput. A PRISMA 2020-compliant review process was used, including structured searches of PubMed, Scopus, IEEE Xplore, and Web of Science. Screening, extraction, risk-of-bias assessment, and narrative synthesis were conducted to compare model targets, data sources, validation approaches, and implementation maturity. The evidence base was dominated by retrospective studies of patient throughput, emergency department admission prediction, bed demand, and length of stay. Staffing, equipment, and diagnostic capacity forecasting were less frequently represented, while integrated multi-resource command centre models remained uncommon. Machine learning for hospital resource allocation has become technically advanced, but operational translation remains uneven. Most models remained retrospective or locally validated, with limited evidence of prospective deployment, workflow integration, or measurable operational impact.

Revenue cycle inefficiencies, including claim denials, coding errors, delayed reimbursement, and prior authorization workload, impose substantial administrative and financial burdens on healthcare organizations. Machine learning has been proposed as a decision-support approach for improving prediction, automation, and workflow prioritization in these areas. This systematic review examined peer-reviewed and closely related scholarly literature from 2017 to 2023 on machine learning for healthcare revenue cycle analytics. The review focused on claim denial prediction, coding automation, payment delay forecasting, and prior authorization support. A PRISMA 2020-compliant review process was used, including structured database searching, dual screening, and domain-based narrative synthesis. Risk of bias was assessed using criteria adapted from PROBAST-AI, with attention to temporal validation, data leakage, and implementation relevance. The literature showed the greatest maturity in automated clinical coding and emerging but narrower evidence for claim denial prediction. Evidence for payment delay forecasting and prior authorization support was more limited, with few studies describing prospective implementation or measured operational impact. Machine learning shows promise for improving revenue cycle decision support, but most evidence remains retrospective and technically oriented. Deployment is constrained by data fragmentation, explainability requirements, workflow integration, and regulatory caution.

Smart hospitals increasingly combine artificial intelligence, real-time data streams, operational dashboards, and automated decision support to coordinate care delivery. These systems aim to improve hospital throughput, staff efficiency, resource use, and patient safety. This systematic review synthesised evidence on AI technologies used in smart hospital management from 2017 to 2023. The review focused on command centers, real-time workflow monitoring, operational dashboards, and automated decision support systems. A PRISMA 2020-compliant review process was used, including structured database searching, dual screening, and narrative synthesis. Extracted data covered study characteristics, AI methods, deployment maturity, data sources, integration patterns, and reported operational impact. The evidence base was concentrated on hospital command centers, predictive dashboards, and patient-flow analytics. Real-time workflow monitoring and automated decision support were less mature, and prospective evaluations of operational or clinical impact were uncommon. AI-enabled smart hospital management is technologically promising but remains unevenly implemented and weakly evaluated. Current evidence supports cautious adoption, local validation, and stronger evaluation designs before claims of sustained operational transformation are accepted.

Healthcare quality improvement increasingly relies on routinely collected data to identify preventable harm, missed care opportunities, adverse outcomes, and variation in performance. Artificial intelligence predictive models may support earlier detection of quality risks and enable more proactive monitoring than retrospective audits alone. This systematic review examined artificial intelligence predictive models for healthcare quality improvement from 2017 to 2024. The review focused on patient safety events, care gaps, adverse clinical outcomes, and performance monitoring systems. A PRISMA 2020-compliant search was conducted across PubMed, Scopus, Web of Science, and IEEE Xplore for peer-reviewed English-language studies published from 2017 through 2024. Dual screening, structured data extraction, risk-of-bias assessment, and narrative synthesis were used. The evidence base showed growing use of machine learning for pressure injuries, sepsis, readmission, mortality, ICU transfer, and continuous monitoring. However, most studies remained retrospective model-development or validation studies, while fewer described deployment within formal quality improvement workflows. Technical progress in predictive modelling for quality improvement is substantial, but evidence of sustained improvement in care processes, safety outcomes, or organisational performance remains limited. Stronger prospective evaluation and clearer integration with improvement methods are needed.

Hospital patient flow depends on timely transfer decisions, accurate discharge planning, and reliable post-discharge coordination. Delays in placement, premature discharge, missed follow-up, and unrecognized post-discharge risk can increase avoidable utilization and compromise continuity of care. This systematic review examined machine learning models for predicting placement delay, discharge readiness, follow-up completion, and post-discharge risk from 2017 to 2024. The objective was to synthesize model purposes, data sources, validation practices, implementation maturity, and practical relevance for care transitions. A PRISMA 2020-compliant systematic review was conducted using PubMed, Scopus, IEEE Xplore, and Web of Science. Dual screening, structured data extraction, and narrative synthesis were used because heterogeneity in model objectives, predictors, settings, and outcomes prevented meta-analysis. The evidence base was largest for post-discharge readmission risk and discharge readiness prediction, while placement delay and follow-up completion received less focused attention. Prospective validation, workflow integration, and outcome-based implementation studies were uncommon across all four domains. Machine learning offers promising tools to support proactive discharge planning and transitional care, but the evidence remains dominated by retrospective model development. Translation into routine practice requires prospective testing, interpretability, equity assessment, and integration into multidisciplinary workflows.

Artificial intelligence models are increasingly used to support healthcare decision-making, resource allocation, clinical triage, population health management, and quality improvement. Without explicit equity assessment, these tools may reproduce, obscure, or scale existing disparities across racial, ethnic, sex, gender, socioeconomic, and geographic groups. This systematic review examined artificial intelligence approaches for healthcare equity analytics from 2017 to 2024. The review focused on bias detection, fairness-aware prediction, disparity monitoring, and algorithmic accountability in health systems. A PRISMA 2020-compliant search was conducted across PubMed, Scopus, Web of Science, and IEEE Xplore for peer-reviewed English-language studies published between 2017 and 2024. Eligible records were screened by two reviewers, and findings were synthesised narratively by equity task, method type, clinical application, fairness metric, and implementation context. The evidence base showed increasing attention to bias detection and fairness-aware algorithm design, especially in clinical risk prediction, diagnostic imaging, and population health management. Disparity monitoring systems and accountability structures were less frequently evaluated in deployed health system environments and were commonly described as governance recommendations, audit frameworks, or pilot-stage approaches. The technical foundations for equitable artificial intelligence in healthcare are advancing, but translation into operational health system practice remains limited. The strongest evidence concerns bias measurement, whereas evidence that fairness interventions reduce real-world health disparities remains nascent.

Healthcare administration generates large volumes of textual data, including clinical notes, billing documentation, incident narratives, portal messages, and operational records. These data create administrative burden but also provide opportunities for natural language processing to support documentation, coding, communication, safety review, and workflow automation. This systematic review examined natural language processing models applied to healthcare administration from 2017 to 2024. The review focused on five domains: clinical documentation, coding support, incident reporting, patient communication, and workflow automation. A PRISMA 2020-compliant review was conducted using structured searches of PubMed, Scopus, IEEE Xplore, and Web of Science for studies published between 2017 and 2024. Eligible studies were screened by two reviewers, extracted using a structured template, and synthesized narratively by administrative domain, model type, evaluation approach, and implementation maturity. Transformer-based models were increasingly prominent across the reviewed literature, particularly in documentation support, automated coding, and clinical text classification. Clinical documentation and coding support had the strongest evidence base, while incident reporting, patient communication, and workflow automation remained less mature and less frequently evaluated in real-world settings. Natural language processing for healthcare administration is technically promising, but most applications remain at the retrospective or proof-of-concept stage. Prospective validation, workflow integration, governance, and human oversight are needed before widespread operational adoption.